|
|
Office Locations:
|
101 CALIFORNIA STREET 44TH FLOOR
San Francisco, CA 94111
Phone: 212-583-5000
Fax: 650-238-5001
| |
|
|
|
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
|
Formerly Clarus Ventures, Blackstone Life Sciences (BXLS) works in partnership with the pharmaceutical, biotechnology and medical technology industries In 2018, Blackstone acquired Clarus, a leading global life sciences firm. Blackstone Life Sciences combines Clarus' scientific and clinical development expertise with Blackstone's knowledge and global network, access to capital, resources and infrastructure. The firm commits skill and scale to select, fund and advance what we believe to be the most promising life science products through hands-on involvement and directly applied expertise. Investments have brought 111 medicines to market.
|
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
